Patent · US Expired

Peptide inhibitors of protein kinase C

US7393835B2 · kind B2 · utility

8Cited by
7References
8Claims
0Family size

Assignee

Inventor

Key dates

Filing dateApr 22, 2003
Grant dateJul 1, 2008
Priority date
Expiry dateApr 22, 2023

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K7/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

PKC V5 isozyme-specific peptides are described. The sequences and compositions comprising the sequences are useful for treating diseases states associated with the PKC isozyme from which they are respectively derived. Methods of treatment, pharmaceutical formulations and methods of identifying compounds that mimic the activity of the peptides are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.